Quality by Design Approach: Progress in Pharmaceutical Method Development and Validation
Avinash V. Chavan1
and R. Gandhimathi1*Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies(VISTAS), Pallavaram, Chennai-600117, Tamil Nadu, India.
Corresponding Author E-mail: avinashchavan9696@gmail.com
Abstract: Pharmaceutical analysis plays a significant role in pharmaceutical formulation quality assurance and control. Due to the pharmaceutical industries' rapid expansion and the production of pharmaceuticals all over the world, there is a greater need for novel analytical procedures in this sector. Establishing the identification, purity, physical properties, and potency of medications as well as the medication's bioavailability and stability is the goal of analytical method development. A few new drug applications were recently given regulatory flexibility by the Food and Drug Administration for an analytical method based on quality by design. With Quality by design, product design and development are performed methodically. Analytical methodologies have similar opportunities for implementing Quality by design as production procedures do. It consequently enhances formulation design, development efficiency, and capacity. The underpinnings of the QbD approach have been explored in this article due to their use in the creation and validation of analytical procedures. Additionally, a summary of experimental studies reporting the application of the QbD methodology to method development is included.
Keywords: Design of Expert; Method Development; Pharmaceutical Analysis; Quality by Design; Validation Back to TOC